Charles River Laboratories International CRL
NYSE CRL
$282.06 +8.65 (+3.16%)
As of: Sep 17, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) Selling, General & Administrative (2009 - 2026)

Analysis

Charles River Laboratories International (CRL) Selling, General & Administrative (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 574.00 Mn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 48.10 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 194.32 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 228.90 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 102.10 Mn
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 30.78 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 2.67 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn 2.79 Bn
10 VivoSim Labs 1.37 Mn 1.37 Mn - 1.65 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 228.90 Mn
Mar 28, 2026 159.42 Mn
Dec 27, 2025 196.14 Mn
Sep 27, 2025 177.59 Mn
Jun 28, 2025 191.55 Mn
Mar 29, 2025 177.80 Mn
Dec 28, 2024 195.71 Mn
Sep 28, 2024 199.21 Mn
Jun 29, 2024 169.79 Mn
Mar 30, 2024 186.29 Mn
Dec 30, 2023 197.14 Mn
Sep 30, 2023 176.11 Mn
Jul 1, 2023 199.76 Mn
Apr 1, 2023 174.85 Mn
Dec 31, 2022 199.64 Mn
Sep 24, 2022 183.71 Mn
Jun 25, 2022 131.71 Mn
Mar 26, 2022 150.03 Mn
Dec 25, 2021 144.11 Mn
Sep 25, 2021 148.57 Mn